Mao YuMin - Net Worth and Insider Trading

Mao YuMin Net Worth

The estimated net worth of Mao YuMin is at least $206 Million dollars as of 2025-03-05. Mao YuMin is the 2101 Beneficial owner of Innovative Pharmaceutical Biotech Ltd and owns about 1,129,970,810 shares of Innovative Pharmaceutical Biotech Ltd (HKSE:00399) stock worth over $206 Million. Details can be seen in Mao YuMin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Mao YuMin has not made any transactions after 2024-01-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

Transaction Summary of Mao YuMin

Mao YuMin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mao YuMin owns 1 companies in total, including Innovative Pharmaceutical Biotech Ltd (HKSE:00399) .

Click here to see the complete history of Mao YuMin’s form 4 insider trades.

Insider Ownership Summary of Mao YuMin

Ticker	Comapny	Transaction Date	Type of Owner
HKSE:00399	Innovative Pharmaceutical Biotech Ltd	2024-01-10	2101 Beneficial owner

Mao YuMin Latest Holdings Summary

Mao YuMin currently owns a total of 1 stock. Mao YuMin owns 1,129,970,810 shares of Innovative Pharmaceutical Biotech Ltd (HKSE:00399) as of January 10, 2024, with a value of $206 Million.

Latest Holdings of Mao YuMin

Ticker	Comapny	Latest Transaction Date	Shares Owned	Current Price ($)	Current Value ($)
HKSE:00399	Innovative Pharmaceutical Biotech Ltd	2024-01-10	1,129,970,810	0.18	205,654,687

Holding Weightings of Mao YuMin

Mao YuMin Form 4 Trading Tracker

According to the SEC Form 4 filings, Mao YuMin has made a total of 4 transactions in Innovative Pharmaceutical Biotech Ltd (HKSE:00399) over the past 5 years, including 0 buys and 2 sells. The most-recent trade in Innovative Pharmaceutical Biotech Ltd is the sale of 0 shares on January 10, 2024, which brought Mao YuMin around $0.

Insider Trading History of Mao YuMin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.

Total 0

Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Mao YuMin Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mao YuMin Ownership Network

Ownership Network List of Mao YuMin

No Data

Ownership Network Relation of Mao YuMin

Mao YuMin Owned Company Details

What does Innovative Pharmaceutical Biotech Ltd do?

Who are the key executives at Innovative Pharmaceutical Biotech Ltd?

Mao YuMin is the 2101 Beneficial owner of Innovative Pharmaceutical Biotech Ltd. Other key executives at Innovative Pharmaceutical Biotech Ltd include 2101 Beneficial owner Mao Yumin , 2101 Beneficial owner Chau Yiu Ting , and Extrawell Pharmaceutical Holdings Limited .

Innovative Pharmaceutical Biotech Ltd (HKSE:00399) Insider Trades Summary

Over the past 18 months, Mao YuMin made 4 insider transaction in Innovative Pharmaceutical Biotech Ltd (HKSE:00399) with a net sale of 100,000,000. Other recent insider transactions involving Innovative Pharmaceutical Biotech Ltd (HKSE:00399) include a net sale of 50,000,000 shares made by Mao Yumin , a net sale of 0 shares made by Extrawell Pharmaceutical Holdings Limited , and a net sale of 64,245,000 shares made by Chau Yiu Ting .

In summary, during the past 3 months, insiders sold 23,695,000 shares of Innovative Pharmaceutical Biotech Ltd (HKSE:00399) in total and bought 0 shares, with a net sale of 23,695,000 shares. During the past 18 months, 214,245,000 shares of Innovative Pharmaceutical Biotech Ltd (HKSE:00399) were sold and 100,000,000 shares were bought by its insiders, resulting in a net sale of 114,245,000 shares.

Innovative Pharmaceutical Biotech Ltd (HKSE:00399)'s detailed insider trading history can be found in Insider Trading Tracker table.

Innovative Pharmaceutical Biotech Ltd Insider Transactions

No Available Data

Mao YuMin Mailing Address

Above is the net worth, insider trading, and ownership report for Mao YuMin. Currently GuruFocus does not have mailing address information for Mao YuMin.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.